Stay updated on Oral Gallium Maltolate for Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Oral Gallium Maltolate for Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Gallium Maltolate for Glioblastoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:25:24.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the dosage of Gallium maltolate in a phase 1 investigational study for the treatment of relapsed and refractory glioblastoma.
    Difference
    0.1%
    Check dated 2024-06-06T14:35:49.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed information about eligibility criteria for study participants, including examples and specific inclusion criteria such as voluntary written consent and prior treatments. Previously, this section only indicated that no information was provided.
    Difference
    43%
    Check dated 2024-05-22T21:36:51.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:35:56.000Z thumbnail image

Stay in the know with updates to Oral Gallium Maltolate for Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Gallium Maltolate for Glioblastoma Clinical Trial page.